Larger effect sizes were associated with higher quality ratings in complementary and alternative medicine randomized controlled trials

被引:7
作者
Bausell, RB
Lee, WL
Soeken, KL
Li, YF
Berman, BM
机构
[1] Univ Maryland, Sch Nursing, Baltimore, MD 21201 USA
[2] Univ Maryland, Kernan Hosp Mans, Sch Med, Complementary Med Program, Baltimore, MD 21207 USA
[3] VA Puget Sound Hlth Care Syst, Seattle, WA 98108 USA
基金
美国国家卫生研究院;
关键词
randomized controlled trials; complementary and alternative medicine; trial quality; effect sizes;
D O I
10.1016/j.jclinepi.2003.11.001
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective: To determine if the quality of, complementary and alternative medicine (CAM) placebo controlled randomized controlled trials (RCTs) is related to the effect sizes they produce when the type of interventions and outcome variables are controlled. Study Design and Setting: A sample of 25 CAM meta-analyses was identified from MEDLINE and hand searches containing published effect sizes for at least three efficacy trials employing placebo control groups. From these 25 reviews, 26 pairs of trials were selected: the one reporting the largest effect size and the matching trial reporting the smallest effect size. Quality and publication characteristics were then abstracted from each trial. Results: Unlike the preponderance of past evidence examining the relationship between quality and effect size, the present study found that trials possessing the largest effect sizes within a meta-analysis were also associated with higher quality ratings than their counterparts possessing the lowest effect sizes (P = .019). Conclusions: Possible theoretical reasons for this unexpected positive relationship include (a) sampling error, (b) reduced within group variation, (c) fraudulent reporting, and (d) the restriction of the analyses to placebo controlled trial. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:438 / 446
页数:9
相关论文
共 53 条
[1]
The revised CONSORT statement for reporting randomized trials: Explanation and elaboration [J].
Altman, DG ;
Schulz, KF ;
Moher, D ;
Egger, M ;
Davidoff, F ;
Elbourne, D ;
Gotzsche, PC ;
Lang, T .
ANNALS OF INTERNAL MEDICINE, 2001, 134 (08) :663-694
[2]
Correlation of quality measures with estimates of treatment effect in meta-analyses of randomized controlled trials [J].
Balk, EM ;
Bonis, PAL ;
Moskowitz, H ;
Schmid, CH ;
Ioannidis, JPA ;
Wang, CC ;
Lau, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (22) :2973-2982
[3]
BAUSELL RB, 2002, POWDER ANAL EXPT RES
[4]
Measuring the quality of trials - The quality of quality scales [J].
Berlin, JA ;
Rennie, D .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (11) :1083-1085
[5]
Evaluation of randomized controlled trials on complementary and alternative medicine [J].
Bloom, BS ;
Retbi, A ;
Dahan, S ;
Jonsson, E .
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2000, 16 (01) :13-21
[6]
DISCORDANCE BETWEEN METAANALYSES AND LARGE-SCALE RANDOMIZED, CONTROLLED TRIALS - EXAMPLES FROM THE MANAGEMENT OF ACUTE MYOCARDIAL-INFARCTION [J].
BORZAK, S ;
RIDKER, PM .
ANNALS OF INTERNAL MEDICINE, 1995, 123 (11) :873-877
[7]
The placebo effect [J].
Brown, WA .
SCIENTIFIC AMERICAN, 1998, 278 (01) :90-95
[8]
Large trials vs meta-analysis of smaller trials - How do their results compare? [J].
Cappelleri, JC ;
Ioannidis, JPA ;
Schmid, CH ;
deFerranti, SD ;
Aubert, M ;
Chalmers, TC ;
Lau, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (16) :1332-1338
[9]
BIAS IN TREATMENT ASSIGNMENT IN CONTROLLED CLINICAL-TRIALS [J].
CHALMERS, TC ;
CELANO, P ;
SACKS, HS ;
SMITH, H .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (22) :1358-1361
[10]
EVIDENCE FAVORING USE OF ANTICOAGULANTS IN HOSPITAL PHASE OF ACUTE MYOCARDIAL-INFARCTION [J].
CHALMERS, TC ;
MATTA, RJ ;
SMITH, H ;
KUNZLER, AM .
NEW ENGLAND JOURNAL OF MEDICINE, 1977, 297 (20) :1091-1096